- Home
- SABS vs SKK Comparison
SABS vs SKK Comparison
Compare SABS & SKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- SKK
- Stock Information
- Founded
- SABS 2014
- SKK 2013
- Country
- SABS United States
- SKK Singapore
- Employees
- SABS N/A
- SKK N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- SKK
- Sector
- SABS Health Care
- SKK
- Exchange
- SABS Nasdaq
- SKK NYSE
- Market Cap
- SABS 11.4M
- SKK 12.3M
- IPO Year
- SABS N/A
- SKK 2024
- Fundamental
- Price
- SABS $1.37
- SKK $0.72
- Analyst Decision
- SABS Strong Buy
- SKK
- Analyst Count
- SABS 5
- SKK 0
- Target Price
- SABS $11.40
- SKK N/A
- AVG Volume (30 Days)
- SABS 25.6K
- SKK 121.6K
- Earning Date
- SABS 05-19-2025
- SKK 02-14-2025
- Dividend Yield
- SABS N/A
- SKK N/A
- EPS Growth
- SABS N/A
- SKK N/A
- EPS
- SABS N/A
- SKK N/A
- Revenue
- SABS $1,322,410.00
- SKK $8,631,000.00
- Revenue This Year
- SABS N/A
- SKK N/A
- Revenue Next Year
- SABS $50.00
- SKK N/A
- P/E Ratio
- SABS N/A
- SKK N/A
- Revenue Growth
- SABS N/A
- SKK N/A
- 52 Week Low
- SABS $1.00
- SKK $0.61
- 52 Week High
- SABS $5.01
- SKK $11.45
- Technical
- Relative Strength Index (RSI)
- SABS 46.90
- SKK N/A
- Support Level
- SABS $1.30
- SKK N/A
- Resistance Level
- SABS $1.49
- SKK N/A
- Average True Range (ATR)
- SABS 0.13
- SKK 0.00
- MACD
- SABS 0.04
- SKK 0.00
- Stochastic Oscillator
- SABS 75.51
- SKK 0.00
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About SKK SKK HOLDINGS LIMITED
SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are primarily the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.